How this instrument works
The Framingham General Cardiovascular Risk Profile estimates the probability that a person will have a first cardiovascular event — coronary heart disease, stroke, peripheral artery disease, or heart failure — within the next 10 years. It was derived from decades of follow-up data in the Framingham Heart Study cohort and published by D'Agostino and colleagues in 2008 as a sex-specific, log-linear model built from age, total cholesterol, HDL cholesterol, systolic blood pressure, smoking status, diabetes status, and whether blood pressure is being treated with medication.
The model produces separate equations for men and women because the same risk factors carry different weights by sex — the coefficients on age, cholesterol, HDL, and smoking all differ, and so does the baseline survival constant each sex's score is compared against. A raw weighted sum (the log-linear score) is combined with a sex-specific baseline survival probability to produce a final 10-year risk percentage.
One detail worth understanding directly: systolic blood pressure enters the formula with one of two different coefficients depending on whether the patient is already being treated with antihypertensive medication. The same measured SBP value produces a higher weighted contribution to risk if it's on treatment than if it's untreated — the model is, in effect, crediting treated hypertension as a marker of a higher underlying risk trajectory than an identical untreated reading would represent.
This is a population-level, primary-prevention risk-prediction tool intended for adults roughly 30 to 74 years old who have not already had a cardiovascular event. It is not a diagnostic test, and it is worth knowing that clinical practice has continued to evolve since 2008: many current guidelines, particularly in the US, now favor the ACC/AHA Pooled Cohort Equations (introduced 2013) or other updated risk models for some decisions, such as statin-initiation thresholds. Framingham's general CVD profile remains widely used and cited, but it is one of several risk calculators in circulation rather than the single current standard, and the right tool can depend on which guideline a clinician is following.
- Select the patient's sex (the 'Sex is female' toggle) — the calculator uses entirely different coefficients for men and women.
- Enter age in years (the model is validated for roughly 30-74).
- Enter total cholesterol in mg/dL.
- Enter HDL cholesterol in mg/dL.
- Enter systolic blood pressure in mmHg.
- Select whether the patient is on blood-pressure medication — this changes which SBP coefficient is applied.
- Select current smoking status (Yes/No).
- Select diabetic status (Yes/No).
- Read the weighted SBP term, the overall weighted sum, the sex-specific baseline survival constant, and the final 10-year cardiovascular disease risk percentage.
Worked example — a 55-year-old woman and man with identical values
A 55-year-old woman with total cholesterol 213 mg/dL, HDL 50 mg/dL, untreated SBP 120 mmHg, no smoking, and no diabetes: the weighted SBP term is about 13.221, the overall weighted sum is about 0.0715, and against the female baseline survival constant of 0.95012, that works out to an estimated 10-year cardiovascular risk of about 5.3%.
A 55-year-old man with the exact same values — same cholesterol, HDL, SBP, and no smoking or diabetes — uses different coefficients and a male baseline survival constant of 0.88936 instead. His weighted sum comes out to about -0.0827, and his estimated 10-year risk is about 10.2%, roughly double the woman's estimate despite identical risk-factor values, illustrating why the model is sex-specific rather than a single shared equation.
A higher-risk profile makes the treated-SBP coefficient concrete: a 60-year-old woman with cholesterol 240, HDL 40, SBP 150 that is being treated with medication, who smokes and has diabetes, gets the treated coefficient (2.82263, versus 2.76157 if the same SBP were untreated). Her weighted SBP term is about 14.143, her overall weighted sum is about 2.719, and her estimated 10-year risk comes out to about 54.0%.
Questions
Is this the same as the newer ACC/AHA Pooled Cohort Equations?
No. This calculator implements the 2008 D'Agostino Framingham General Cardiovascular Risk Profile specifically. The ACC/AHA Pooled Cohort Equations, introduced in 2013 and used in many current US guidelines (for example, to help decide when to start a statin), are a separate, more recently derived model built from different cohort data with somewhat different risk factors and outputs. The two calculators can give different risk estimates for the same patient, and which one a clinician relies on often depends on which guideline they're following.
Why does being on blood-pressure medication change the risk estimate?
The original Framingham model found that treated hypertension carries a different (higher) risk association at any given SBP reading than the same SBP value would represent if untreated — likely because being on treatment is itself a marker of a more significant underlying hypertension history. The formula accounts for this by applying a different coefficient to ln(SBP) depending on treatment status, so two patients with an identical measured SBP can get different weighted contributions to their score.
Who is this risk score meant for?
Adults roughly 30 to 74 years old with no prior cardiovascular event — it's a primary-prevention tool for estimating first-event risk, not for someone who has already had a heart attack, stroke, or other cardiovascular diagnosis, and not a pediatric or young-adult tool. It's intended to support a clinician's discussion of risk and prevention, not to be interpreted as a standalone verdict.
Does a low percentage mean no risk at all?
No. The output is a probability estimate over a 10-year horizon based on population data, not a guarantee. Individuals with a 'low' calculated risk can still have cardiovascular events, and the model doesn't capture every risk factor (for example, family history, lipoprotein(a), or inflammatory markers) that might matter for a particular patient.
What inputs does the calculator need?
Sex, age, total cholesterol, HDL cholesterol, systolic blood pressure, whether that blood pressure is being treated with medication, current smoking status, and diabetic status. All seven factors feed into the sex-specific weighted sum that produces the final risk percentage.
Can this replace a cardiologist's assessment?
No. It performs the published arithmetic on the values entered; it doesn't review imaging, family history, medication history, or other clinical context. Risk estimates like this are meant to inform a conversation between patient and clinician about prevention strategy, not to stand in for individualized clinical evaluation.
References
- D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. — General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation. 2008;117(6):743-753 (PMID 18212285)
- Goff DC Jr, et al. — 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk (Pooled Cohort Equations), Circulation. 2014;129(25 Suppl 2):S49-73
Read this first: This instrument computes a screening figure from population formulas — it is not a diagnosis, and it cannot see the whole picture a clinician can. Use it to inform a conversation, not to replace one.